Cargando…
Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19(+) B cells in patients with ankylosing spondylitis
OBJECTIVE: IL-35 is a potent immunosuppressive and anti-inflammatory cytokine, consisting of a p35 subunit and an Epstein–Barr virus–induced gene 3 (EBI3) subunit, which suppresses CD4(+) effector T cell proliferation and promotes regulatory T cell (Treg) expansion. However, the effects of IL-35 on...
Autores principales: | Zhang, Yu, Wei, Sixi, Wu, Qingqing, Shen, Xue, Dai, Wanrong, Zhang, Zhiqi, Chen, Man, Huang, Hai, Ma, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287221/ https://www.ncbi.nlm.nih.gov/pubmed/35420296 http://dx.doi.org/10.1007/s10067-022-06137-8 |
Ejemplares similares
-
Interleukin-17 Inhibitors for the Treatment of Ankylosing Spondylitis
por: Huang, Jin-Xian, et al.
Publicado: (2020) -
Neutrophil Extracellular Traps and Interleukin 17 in Ankylosing Spondylitis
por: Papagoras, Charalampos, et al.
Publicado: (2021) -
Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity
por: Chen, Bingni, et al.
Publicado: (2015) -
Elevated serum interleukin-23 levels in ankylosing spondylitis patients and the relationship with disease activity
por: Ugur, Mahir, et al.
Publicado: (2015) -
High level of interleukin-32 gamma in the joint of ankylosing spondylitis is associated with osteoblast differentiation
por: Lee, Eun-Ju, et al.
Publicado: (2015)